US Map / Indiana
State IN

Clinical Trials in Indiana

Indiana is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Indiana and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 178 actively recruiting studies with Indiana sites out of 178 registered in total. The busiest research areas in Indiana are Heart Failure, Cancer, Prostate Cancer. Leading sponsors running trials in the state include Indiana University, Bristol-Myers Squibb, National Cancer Institute (NCI). By stage, Indiana trials break down as Phase 1 (17), Phase 2 (44), Phase 3 (55), Phase 4 (7).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
178
Recruiting Now
178
← Back to US Map
Top Conditions in Indiana
Heart Failure (5)Cancer (4)Prostate Cancer (3)Stroke (3)Atrial Fibrillation (AF) (2)Recurrent Malignant Solid Neoplasm (2)Triple Negative Breast Cancer (2)Ulcerative Colitis (2)Primary Membranous Nephropathy (2)Large B-cell Lymphoma (2)Non-Small Cell Lung Cancer (2)Obesity (2)

Frequently Asked Questions — Clinical Trials in Indiana

How many clinical trials are currently recruiting in Indiana?
ClinicalMetric currently tracks 178 actively recruiting clinical trials with at least one location in Indiana. The total number of registered studies—including active but not currently enrolling trials—is 178. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Indiana?
Indiana hosts clinical trials across a broad range of medical conditions, including Heart Failure, Cancer, Prostate Cancer, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Indiana serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Indiana?
To join a clinical trial in Indiana, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Indiana maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Indiana

NCT05701917 N/A
Recruiting
DEFIANCE: RCT of ClotTriever System Versus Anticoagulation In Deep Vein Thrombos...
Condition
Venous Thromboembolism
Enrollment
300 pts
Location
United States, Austria, Finland
Sponsor
Inari Medical
View Trial →
NCT07140913 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatmen...
Condition
Mania
Enrollment
424 pts
Location
United States, Argentina, Bulgaria
Sponsor
Bristol-Myers Squibb
View Trial →
NCT07096843 Phase 2
Recruiting
A Phase 2 Study of Budoprutug in Subjects With Primary Membranous Nephropathy
Condition
Primary Membranous Nephropathy
Enrollment
45 pts
Location
United States, Argentina, Brazil
Sponsor
Climb Bio, Inc.
View Trial →
NCT06867185 N/A
Recruiting
Evaluating Therapeutic Electrical Stimulation to Improve Nerve Healing After Sur...
Condition
Digital Nerve Injury
Enrollment
60 pts
Location
United States
Sponsor
Checkpoint Surgical Inc.
View Trial →
NCT07392255 Phase 1, Phase 2
Recruiting
An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx00...
Condition
Geographic Atrophy Secondary to Age-related Macular Degeneration
Enrollment
75 pts
Location
United States, United Kingdom
Sponsor
Complement Therapeutics
View Trial →
NCT06030063 N/A
Recruiting
The Society for Obstetric Anesthesia and Perinatology Research Network General A...
Condition
Cesarean Delivery
Enrollment
5,000 pts
Location
United States, Canada
Sponsor
Yale University
View Trial →
NCT06965504 N/A
Recruiting
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure ...
Condition
Heart Failure
Enrollment
250 pts
Location
United States
Sponsor
Abiomed Inc.
View Trial →
NCT00009633 N/A
Recruiting
Follow-up Visit of High Risk Infants
Condition
Infant, Newborn
Enrollment
68,000 pts
Location
United States
Sponsor
NICHD Neonatal Research Networ
View Trial →
NCT06915363 N/A
Recruiting
BioPoly® Partial Resurfacing Knee Implant IDE
Condition
Knee Pain Chronic
Enrollment
152 pts
Location
United States
Sponsor
BioPoly LLC
View Trial →
NCT06747117 N/A
Recruiting
A Study of Patients With Lower Extremity Acute Limb Ischemia to Remove Thrombus ...
Condition
Lower Extremity Acute Limb Ischemia
Enrollment
300 pts
Location
United States, Australia, Brazil
Sponsor
Penumbra Inc.
View Trial →
NCT06628908 Phase 3
Recruiting
Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabet...
Condition
Diabetic Peripheral Neuropathic Pain
Enrollment
1,100 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
View Trial →
NCT06080789 Phase 2
Recruiting
A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Part...
Condition
Acute Pancreatitis
Enrollment
36 pts
Location
United States, India
Sponsor
Panafina, Inc.
View Trial →
NCT06625385 N/A
Recruiting
A Study Evaluating the Safety and Efficacy of the 3M™ V.A.C. Peel and Place Dres...
Condition
Wound
Enrollment
90 pts
Location
United States
Sponsor
Solventum US LLC
View Trial →
NCT06462235 Phase 2
Recruiting
A Study to Learn About the Study Medicine Aztreonam-Avibactam (ATM-AVI) in Infan...
Condition
Gram-negative Bacterial Infection
Enrollment
48 pts
Location
United States, Argentina, Bulgaria
Sponsor
Pfizer
View Trial →
NCT06551116 N/A
Recruiting
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 i...
Condition
HER2-positive Metastatic Breast Cancer
Enrollment
200 pts
Location
United States
Sponsor
Abramson Cancer Center at Penn
View Trial →
NCT06915038 N/A
Recruiting
ctHPVDNA in HPV Positive Squamous Cell Carcinoma of the Oropharynx
Condition
Squamous Cell Carcinoma of Oropharynx
Enrollment
120 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT04649242 Phase 3
Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
Condition
Pediatric Migraine
Enrollment
2,100 pts
Location
United States, Canada, China
Sponsor
Pfizer
View Trial →
NCT04181138 N/A
Recruiting
Primary Sclerosing Cholangitis in Children
Condition
Primary Sclerosing Cholangitis
Enrollment
1,000 pts
Location
United States, Canada
Sponsor
Arbor Research Collaborative f
View Trial →
NCT07360938 N/A
Recruiting
Drug Interaction Potential of Pro-Inflammatory Conditions
Condition
Diabetes Mellitus, Type 2
Enrollment
150 pts
Location
United States
Sponsor
Indiana University
View Trial →
NCT06750094 Phase 3
Recruiting
A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in P...
Condition
Colorectal Neoplasms
Enrollment
700 pts
Location
United States, Australia, Belgium
Sponsor
Janssen Research & Development
View Trial →
NCT05803941 Phase 4
Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With ...
Condition
Prostate Cancer
Enrollment
700 pts
Location
United States, Austria, Belgium
Sponsor
Novartis Pharmaceuticals
View Trial →
NCT05137054 Phase 1
Recruiting
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination Wit...
Condition
Multiple Myeloma
Enrollment
317 pts
Location
United States, France, Greece
Sponsor
Regeneron Pharmaceuticals
View Trial →
NCT07566156 Phase 3
Recruiting
Enfortumab Vedotin in Combination With Pembrolizumab vs. Concurrent Chemoradioth...
Condition
Urothelial Cancer
Enrollment
390 pts
Location
United States, Canada, South Korea
Sponsor
Astellas Pharma Global Develop
View Trial →
NCT06809140 Phase 2
Recruiting
Enfortumab Vedotin Plus Pembrolizumab With Selective Bladder Sparing for Treatme...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
75 pts
Location
United States
Sponsor
Matthew Galsky
View Trial →
NCT07676578 N/A
Recruiting
Overground Virtual Reality (VR) Gait Rehabilitation for Stroke
Condition
Stroke
Enrollment
30 pts
Location
United States
Sponsor
Indiana University
View Trial →
Page 3 of 8 — 178 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: November 2026  ·  Data Methodology